Home » Topics » Conferences

Conferences
RSS

Phase II/III results for Seroquel

July 11, 1997

Natural products for hyperlipidemia

July 11, 1997

ETA receptor blockade for counteracting effects of angiotensin II

July 11, 1997

n-3 fatty acids for prevention of restenosis

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

c-fos gene is implicated in pain states

July 10, 1997

NK1 receptor antagonists for pain

July 10, 1997

SNX-111 and SNX-230, analgesic conopeptides and calcium channel blockers

July 10, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...